Platform Combines Imaging Scans and Clinical Information Systems for Decision Support
By MedImaging International staff writers Posted on 27 Dec 2016 |
Image: The Quantitative Imaging Decision Support (QIDS) software platform (Photo courtesy of Healthmyne).
A US company has showcased a new software platform that brings together Electronic Health Record (EHR) and imaging information for analytics and clinical decision support for radiology and oncology specialties.
The platform combines imaging data, and clinical information sources such as Electronic Medical Records (EMR) and Radio Therapy (RT) data into the primary reading workflow. The platform is designed to improve clinical productivity and has been cleared by the US FDA.
The Quantitative Imaging Decision Support (QIDS) software platform was showcased at the annual Radiological Society of North America (RSNA2016) meeting by HealthMyne (Madison, WI, USA). The software provides curated medical content, evidence-based analysis, and reporting for clinical collaboration and improved patient management, as well as data mining for research purposes. The platform is built around an image analysis engine that generates lung cancer screening information such as tumor size, and Lung-RADS categories, amongst other advanced quantitative metrics. HealthMyne plans to expand the platform to other specialties in the future.
President and CEO of HealthMyne, Arvind Subramanian, said, "Radiologists who efficiently leverage existing clinical systems information and generate new quantitative metrics within the primary read will thrive in the Value-Based world. By automatically providing quantitative data not currently available in the routine clinical workflow, HealthMyne is significantly enhancing collaboration between radiologists and oncologists to deliver precise patient management."
Related Links:
HealthMyne
The platform combines imaging data, and clinical information sources such as Electronic Medical Records (EMR) and Radio Therapy (RT) data into the primary reading workflow. The platform is designed to improve clinical productivity and has been cleared by the US FDA.
The Quantitative Imaging Decision Support (QIDS) software platform was showcased at the annual Radiological Society of North America (RSNA2016) meeting by HealthMyne (Madison, WI, USA). The software provides curated medical content, evidence-based analysis, and reporting for clinical collaboration and improved patient management, as well as data mining for research purposes. The platform is built around an image analysis engine that generates lung cancer screening information such as tumor size, and Lung-RADS categories, amongst other advanced quantitative metrics. HealthMyne plans to expand the platform to other specialties in the future.
President and CEO of HealthMyne, Arvind Subramanian, said, "Radiologists who efficiently leverage existing clinical systems information and generate new quantitative metrics within the primary read will thrive in the Value-Based world. By automatically providing quantitative data not currently available in the routine clinical workflow, HealthMyne is significantly enhancing collaboration between radiologists and oncologists to deliver precise patient management."
Related Links:
HealthMyne
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow